Daniel Fink

Cornell University — United States

Medicine · Health Sciences

53h-index9.5kcitations361works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(57), Endometrial and Cervical Cancer Treatments(51), Uterine Myomas and Treatments(37), Endometriosis Research and Treatment(28), Genetic factors in colorectal cancer(28)

Publications361 total

Prison et privation de liberté en Suisse - Une introduction
IRIS·2025
Local Prediction of Temperate Forest Structure in Eastern North America Using LiDAR, Radar, and Optical Data
2025Open Access
Synergies Between Agricultural Production and Shorebird Conservation With Climate Change in the Central Valley, California, With Optimized Water Allocation and Multi‐Benefit Land Use
Global Change Biology·2025· 1 citedOpen Access
The request for assisted suicide – a challenging topic to teach in medical education. Project report on a compulsory elective course at the Aachen University Hospital
PubMed·2025Open Access
Characterizing Temperate Vegetation Structure in Eastern North America Using GEDI (Abstract ID: B33A-1535)
2024Open Access
Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer
Frontiers in Oncology·2024· 2 citedOpen Access
Supplementary Table from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 2 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Data from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 4 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 4 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 2 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure Legends from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 1 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 1 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 3 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure 3 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Table from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Data from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
Supplementary Figure Legends from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
2023Open Access
page 1 of 19Next →

Frequent Co-authors

Stephen B. Howell(10), Stefan Aebi(9), Patrick Imesch(9), S Nebel(7), Rosmarie Caduff(7), R D Christen(6), Manuel Stucki(6), Aurelia Noske(6), Konstantin J. Dedes(6), Eleftherios Pierre Samartzis(5), Viola Heinzelmann‐Schwarz(5), Bruno Cenni(4), A Nehmé(4), Neville F. Hacker(4), André Fedier(4), U. Haller(4), Holger Moch(4), Mathias K. Fehr(4), Hongtu Zheng(3), Alexander Burges(3)